Agenus
AGEN
#8216
Rank
C$0.49 B
Marketcap
C$10.93
Share price
1.72%
Change (1 day)
96.65%
Change (1 year)

Earnings for Agenus (AGEN)

Earnings in 2026 (TTM): C$0.21 Billion

According to Agenus 's latest financial reports the company's current earnings are C$0.13 Billion. In 2025 the company made an earning of C$74.39 Million, an increase over its 2024 earnings that were of -C$0.17 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Agenus from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) C$0.21 B182.93%
2025 C$74.39 M-145.52%
2024 -C$0.17 Billion-28.13%
2023 -C$0.23 Billion-5.5%
2022 -C$0.25 Billion-556.26%
2021 C$52.73 M-130.37%
2020 -C$0.18 Billion73.75%
2019 -C$99.94 Million-48.74%
2018 -C$0.2 Billion34.32%
2017 -C$0.15 Billion-7.16%
2016 -C$0.16 Billion26.55%
2015 -C$0.13 Billion110.24%
2014 -C$58.77 Million49.12%
2013 -C$39.41 Million
2011 -C$27.21 Million-12.25%
2010 -C$31.01 Million-21.41%
2009 -C$39.46 Million-26.86%
2008 -C$53.95 Million13.72%
2007 -C$47.44 Million-33.4%
2006 -C$71.23 Million-31.84%
2005 -C$0.11 Billion9.74%
2004 -C$95.22 Million-0.8%
2003 -C$95.99 Million17.37%
2002 -C$81.79 Million37.83%
2001 -C$59.34 Million55.99%
2000 -C$38.04 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$37.35 B 17,251.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$10.96 B 4,991.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$16.97 B 7,785.43%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$11.24 B 5,123.53%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
-C$0.47 Billion-315.73%๐Ÿ‡บ๐Ÿ‡ธ USA